Clark D. McKeever

Clark D. McKeever

Corporate Officer/Principal bij
Wyeth-Ayerst Research
Health Technology
Commercial Services
Consumer Non-Durables

Profiel

Clark D.
McKeever
is Medical Director of Accelovance, Inc. He is a Consultant and Investigator of Merck, Searle, Pfizer, Proctor & Gamble, Eli Lilly, and Novartis.
Dr. McKeever is a Member of Pharmacia, Wyeth-Ayerst, Ortho-McNeil, the American Medical Association, the American Academy of Orthopedic Surgeons, the International Society for Clinical Densitometry, the Endocrine Society, and the American Society for Bone and Mineral Research.
He is an Instructor on the Education Committee of Clinical Track for the International Society of Clinical Densitometry.
Dr. McKeever served in the United States Air Force.
He received an MD degree from Thomas Jefferson Medical College.

Actieve functies van Clark D. McKeever

BedrijvenFunctieBegin
Wyeth-Ayerst Research
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -

Eerdere bekende functies van Clark D. McKeever

BedrijvenFunctieEinde
Corporate Officer/Principal -
Pharmacia, Inc.
Corporate Officer/Principal -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Corporate Officer/Principal -
PROCTER & GAMBLE COMPANY Corporate Officer/Principal -
Ervaring van Clark D. McKeever in detail bekijken

Opleiding van Clark D. McKeever

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

93

Eerstegraads connecties

14

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit14

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Pharmacia, Inc.

Wyeth-Ayerst Research

Commercial Services

  1. Beurs
  2. Insiders
  3. Clark D. McKeever
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU